# Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence

> **NCT04976153** · PHASE3 · RECRUITING · sponsor: **Innovacell GmbH** · enrollment: 290 (estimated)

## Conditions studied

- Fecal Incontinence

## Interventions

- **BIOLOGICAL:** aSMDC
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04976153
- **Lead sponsor:** Innovacell GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-11
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04976153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04976153, "Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04976153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*